Skip to main content
. 2010 Jun 7;31(8):1400–1404. doi: 10.1093/carcin/bgq117

Table II.

Association of SNPs in the 8q24 chromosomal region and osteosarcoma by inheritance model

SNP, location (references) Genotype No. control (%) No. cases (%) OR (95% CI) P Ptrend Dominant P Recessive P
8q24 SNPs previously associated with other cancers
    rs620861, 128,404,855 (15,16) G/G 577 (40.4) 49 (49.5) 1 (ref)
A/G 652 (45.6) 39 (39.4) 0.70 (0.45–1.08) 0.11
A/A 201 (14.1) 11 (11.1) 0.64 (0.33–1.25) 0.19 0.086 0.071 0.39
    rs13281615, 128,424,800 (19) A/A 445 (33.2) 37 (39) 1 (ref)
A/G 656 (49) 43 (45.3) 0.79 (0.50–1.25) 0.31
G/G 238 (17.8) 15 (15.8) 0.77 (0.41–1.42) 0.39 0.31 0.27 0.64
    rs10505477, 128,476,625 (39,40) G/G 407 (28.5) 24 (24.2) 1 (ref)
A/G 696 (48.7) 52 (52.5) 1.27 (0.77–2.09) 0.35
A/A 326 (22.8) 23 (23.2) 1.19 (0.66–2.14) 0.57 0.55 0.37 0.95
    rs7014346, 128,493,974 (41,42) G/G 632 (44.3) 37 (37.4) 1 (ref)
A/G 614 (43) 48 (48.5) 1.35 (0.87–2.10) 0.19
A/A 182 (12.8) 14 (14.1) 1.30 (0.69–2.46) 0.42 0.25 0.17 0.73
    rs1447295, 128,554,220 (20,43,44) C/C 1165 (81.5) 77 (77.8) 1 (ref)
A/C 253 (17.7) 22 (22.2) 1.35 (0.82–2.21) 0.24
A/A 11 (0.8) 0 (0) 0 0.44 0.32 0.22
    rs6983267, 128,482,487 (20,40,45) T/T 389 (27.2) 23 (23.2) 1 (ref)
G/T 702 (49.1) 51 (51.5) 1.23 (0.74–2.04) 0.43
G/G 339 (23.7) 25 (25.2) 1.24 (0.69–2.22) 0.47 0.47 0.39 0.75
    rs4242382, 128,586,755 (46) G/G 1168 (81.7) 77 (77.8) 1 (ref)
A/G 249 (17.4) 22 (22.2) 1.37 (0.83–2.24) 0.22
A/A 12 (0.8) 0 (0) 0 0.43 0.31 0.2
    rs7017300, 128,594,450 (23) A/A 1077 (75.4) 67 (67.7) 1 (ref)
A/C 325 (22.7) 31 (31.3) 1.56 (0.99–2.42) 0.051
C/C 27 (1.9) 1 (1) 0.59 (0.08–4.38) 0.60 0.17 0.087 0.48
    rs7837688, 128,608,542 (23,47) G/G 1169 (81.8) 78 (78.8) 1 (ref)
G/T 248 (17.4) 21 (21.2) 1.29 (0.78–2.13) 0.32
T/T 12 (0.8) 0 (0) 0 0.57 0.43 0.21
8q24 SNPs associated with osteosarcoma
    rs185852, 128,362,638 G/G 934 (65.4) 60 (60.6) 1 (ref)
A/G 440 (30.8) 31 (31.3) 1.09 (0.70–1.71) 0.69
A/A 54 (3.8) 8 (8.1) 2.28 (1.04–5.02) 0.039 0.13 0.35 0.043
    rs896324, 128,465,694 A/A 1225 (85.7) 76 (76.8) 1 (ref)
A/G 191 (13.4) 21 (21.2) 1.79 (1.08–2.97) 0.025
G/G 13 (0.9) 2 (2) 2.75 (0.61-12.52) 0.19 0.011 0.02 0.29
    rs10808555, 128,478,693 A/A 679 (47.5) 37 (37.4) 1 (ref)
A/G 595 (41.6) 52 (52.5) 1.61 (1.04–2.48) 0.033
G/G 156 (10.9) 10 (10.1) 1.17 (0.57–2.40) 0.67 0.19 0.05 0.78
    rs17766217, 128,573,679 T/T 531 (37.2) 47 (47.5) 1 (ref)
C/T 692 (48.4) 42 (42.4) 0.69 (0.45–1.07) 0.096
C/C 206 (14.4) 10 (10.1) 0.56 (0.28–1.13) 0.1 0.046 0.05 0.23
    rs12155672, 128,576,206 G/G 366 (25.6) 23 (23.2) 1 (ref)
A/G 728 (50.9) 42 (42.4) 0.92 (0.55–1.56) 0.76
A/A 336 (23.5) 34 (34.3) 1.59 (0.92–2.76) 0.098 0.079 0.6 0.022
    rs7386167, 128,637,894 G/G 618 (43.2) 37 (37.4) 1 (ref)
A/G 626 (43.8) 40 (40.4) 1.07 (0.67–1.69) 0.78
A/A 186 (13) 22 (22.2) 1.95 (1.12–3.39) 0.018 0.041 0.26 0.018
    rs9642880, 128,787,250 G/G 416 (29.2) 39 (39.4) 1 (ref)
G/T 704 (49.4) 42 (42.4) 0.63 (0.40–0.99) 0.048
T/T 306 (21.5) 18 (18.2) 0.62 (0.35–1.11) 0.11 0.065 0.034 0.43

Statistically significant (P < 0.05) SNPs are shown in bold. The ORs and 95% CIs for the SNPs with P < 0.05 in the dominant or recessive models are noted in the text. For SNPs previously associated with other cancers, the representative references for the primary cancer association are cited. No., number; ref, referent genotype.